Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |